Literature DB >> 21190044

Clinical significance of cerebrospinal fluid nitric oxide concentrations in degenerative cervical and lumbar diseases.

Hiroshi Denda1, Shinji Kimura, Akiyoshi Yamazaki, Noboru Hosaka, Yuichi Takano, Kenji Imura, Yoichi Yajiri, Naoto Endo.   

Abstract

In animal models of degenerative lumbar disease, inducible nitric oxide synthase (iNOS) is expressed in macrophages and Schwann cells following compression of the cauda equina. We previously reported that NO metabolites (nitrite plus nitrate: [NOx]) in the cerebrospinal fluid (CSF) correlate with postoperative pain relief in patients with degenerative lumbar disease and with neurologic recovery rate postoperatively or after conservative treatment in patients with spinal cord injury. The objective of the present study was to examine the relationship between [NOx] and neurologic severity, and recovery in degenerative cervical and lumbar diseases. Two hundred fifty-seven cases, including 85 patients with cervical compression myelopathy (CCM), 25 with cervical disc herniation (CDH), 70 with lumbar canal stenosis (LCS), and 77 with lumbar disc herniation (LDH), were examined. The CSF [NOx] was measured using the Griess method. Severity of neurologic impairment and clinical recovery was assessed using the Japanese Orthopedic Association score and Hirabayashi's method. [NOx] in CCM and LCS, but not CDH and LDH groups, was significantly higher than that in controls, and correlated with postoperative recovery rates, but not with preoperative neurologic severity. [NOx] significantly correlated with neurologic recovery following surgery for CCM and LCS.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21190044      PMCID: PMC3065603          DOI: 10.1007/s00586-010-1663-8

Source DB:  PubMed          Journal:  Eur Spine J        ISSN: 0940-6719            Impact factor:   3.134


  25 in total

1.  Cerebrospinal fluid nitric oxide metabolites are novel predictors of pain relief in degenerative lumbar diseases.

Authors:  Shinji Kimura; Kenji Watanabe; Yoichi Yajiri; Seiji Uchiyama; Kazuhiro Hasegawa; Katsuei Shibuki; Naoto Endo
Journal:  Pain       Date:  2001-06       Impact factor: 6.961

2.  Nitric oxide regulation system in degenerative lumbar disease.

Authors:  Takuya Watanabe; Seiya Kato; Kimiaki Sato; Kensei Nagata
Journal:  Kurume Med J       Date:  2005

3.  Spinous process splitting laminectomy for lumbar canal stenosis: a critical appraisal.

Authors:  D Y Lee; S H Lee
Journal:  Minim Invasive Neurosurg       Date:  2008-08

4.  Mechanism of destructive pathologic changes in the spinal cord under chronic mechanical compression.

Authors:  Ichiro Yamaura; Kazunori Yone; Shinji Nakahara; Tomonori Nagamine; Hisatoshi Baba; Kenzo Uchida; Setsuro Komiya
Journal:  Spine (Phila Pa 1976)       Date:  2002-01-01       Impact factor: 3.468

5.  Lumbar spinous process-splitting laminectomy for lumbar canal stenosis. Technical note.

Authors:  Kota Watanabe; Toshihiko Hosoya; Tateru Shiraishi; Morio Matsumoto; Kazuhiro Chiba; Yoshiaki Toyama
Journal:  J Neurosurg Spine       Date:  2005-11

6.  Cerebrospinal fluid nitric oxide metabolites in painful diseases.

Authors:  S Kimura; K Watanabe; Y Yajiri; T Motegi; Y Masuya; K Shibuki; S Uchiyama; T Homma; H E Takahashi
Journal:  Neuroreport       Date:  1999-02-05       Impact factor: 1.837

7.  Nitric oxide via macrophage iNOS induces apoptosis following traumatic spinal cord injury.

Authors:  K Satake; Y Matsuyama; M Kamiya; H Kawakami; H Iwata; K Adachi; K Kiuchi
Journal:  Brain Res Mol Brain Res       Date:  2000-12-28

8.  Nitric oxide in cerebrospinal fluid and local inducible nitric oxide synthase after cauda equina compression in rats.

Authors:  Xianjun Wang; Shinji Kimura; Akiyoshi Kakita; Noboru Hosaka; Hiroshi Denda; Takui Ito; Toru Hirano; Naoto Endo
Journal:  Neuroreport       Date:  2006-10-02       Impact factor: 1.837

9.  Concentration of nitric oxide (NO) in spinal fluid of chronic spinal disease.

Authors:  Y Yumite; K Takeuchi; Y Harada; N Ogawa; H Inoue
Journal:  Acta Med Okayama       Date:  2001-08       Impact factor: 0.892

Review 10.  Molecular biology of cervical myelopathy and spinal cord injury: role of oligodendrocyte apoptosis.

Authors:  David H Kim; Alexander R Vaccaro; Fraser C Henderson; Edward C Benzel
Journal:  Spine J       Date:  2003 Nov-Dec       Impact factor: 4.166

View more
  6 in total

1.  Alteration in chondroitin sulfate proteoglycan expression at the epicenter of spinal cord is associated with the loss of behavioral function in Tiptoe walking Yoshimura mice.

Authors:  Jun Wang; Xiaofang Wang; Wei Rong; Jia Lv; Feng Wei; Zhongjun Liu
Journal:  Neurochem Res       Date:  2014-10-02       Impact factor: 3.996

2.  Coexisting lumbar and cervical stenosis (tandem spinal stenosis): an infrequent presentation. Retrospective analysis of single-stage surgery (53 cases).

Authors:  Ajay Krishnan; Bharat R Dave; Arun Kumar Kambar; Himanshu Ram
Journal:  Eur Spine J       Date:  2013-06-24       Impact factor: 3.134

3.  The Presence of the Neuronal Nitric Oxide Synthase Isoform in the Intervertebral Disk.

Authors:  Vitor Castania; Ana Carolina Issy; João Walter Silveira; Frederico Rogério Ferreira; Simoneide S Titze-de-Almeida; Fernando F B Resende; Nádia Rubia Ferreira; Ricardo Titze-de-Almeida; Helton L A Defino; Elaine Del Bel
Journal:  Neurotox Res       Date:  2016-10-19       Impact factor: 3.911

4.  Neurological impairment score in lumbar spinal stenosis.

Authors:  B Micankova Adamova; S Vohanka; M Hnojcikova; I Okacova; L Dusek; J Bednarik
Journal:  Eur Spine J       Date:  2013-03-13       Impact factor: 3.134

5.  Surgical outcomes of single stage surgery for Tandem spinal stenosis (TSS) in elderly and younger patients: A comparative study.

Authors:  Zahir Abbas; Sanjeev Asati; Vishal G Kundnani; Sanyam Jain; Rahul Prakash; Saijyot Raut
Journal:  J Clin Orthop Trauma       Date:  2021-03-18

Review 6.  Neuromodulation via the Cerebrospinal Fluid: Insights from Recent in Vitro Studies.

Authors:  Andreas Bjorefeldt; Sebastian Illes; Henrik Zetterberg; Eric Hanse
Journal:  Front Neural Circuits       Date:  2018-02-05       Impact factor: 3.492

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.